Edap Tms (NASDAQ:EDAP) Upgraded by Wall Street Zen to “Hold” Rating

Wall Street Zen upgraded shares of Edap Tms (NASDAQ:EDAP) to a hold rating in a report published on Saturday morning.

EDAP has been the topic of a number of other research reports. Jefferies Financial Group reissued a “hold” rating and issued a $2.00 price objective on shares of Edap Tms in a research report on Thursday, November 6th. Weiss Ratings reissued a “sell (d-)” rating on shares of Edap Tms in a research report on Monday, December 29th. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $8.50.

Edap Tms Trading Up 18.3%

EDAP opened at $4.73 on Friday. The stock has a market capitalization of $176.86 million, a P/E ratio of -8.30 and a beta of -0.16. The company has a current ratio of 1.41, a quick ratio of 0.97 and a debt-to-equity ratio of 0.04. Edap Tms has a 12 month low of $1.21 and a 12 month high of $4.87. The firm’s fifty day simple moving average is $3.41 and its 200 day simple moving average is $2.52.

Edap Tms (NASDAQ:EDAP) last released its earnings results on Thursday, November 6th. The medical equipment provider reported ($0.15) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.11. The firm had revenue of $16.29 million during the quarter, compared to analysts’ expectations of $15.05 million. Edap Tms had a negative return on equity of 61.60% and a negative net margin of 30.95%. As a group, research analysts anticipate that Edap Tms will post -0.6 EPS for the current fiscal year.

Institutional Investors Weigh In On Edap Tms

Several hedge funds have recently bought and sold shares of EDAP. Sage Mountain Advisors LLC acquired a new position in Edap Tms during the second quarter worth approximately $165,000. Leonteq Securities AG bought a new position in shares of Edap Tms during the 4th quarter worth approximately $313,000. Finally, Financial Planning Navigators CORP acquired a new position in shares of Edap Tms during the 4th quarter worth approximately $33,000. 62.74% of the stock is currently owned by institutional investors and hedge funds.

Edap Tms Company Profile

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.